Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
2020 · Blood Cancer Journal · 109 citations
https://doi.org/10.1038/s41408-020-00377-0
A
Alejandro Medina
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
473
Citations
12
h-index
13
i10-index
Alejandro Medina is an academic researcher from Universidad de Salamanca. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Multiple Myeloma Research and Treatments & Chronic Lymphocytic Leukemia Research. The author has an h-index of 12, co-authored 36 publications.
ORCID: 0000-0001-5609-2969Papers by this author
worksMolecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
2020 · Blood Cancer Journal · 20 citations
https://doi.org/10.1038/s41408-020-0283-8
Clonotypic B Cells are Passengers During Malignant Transformation and not Drivers of Disease Progression in Plasma Cell (PC) Neoplasms
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03446-9
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
2025 · Leukemia · 0 citations
https://doi.org/10.1038/s41375-025-02787-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat